LiberoThera Co., Ltd.
PrivateLast Round
VC Round
Aug 1, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
LiberoThera Co., Ltd. is a biotechnology company that develops novel therapeutics targeting complex membrane proteins, such as G protein-coupled receptors (GPCRs), using proprietary cell-free protein synthesis and non-canonical amino acid incorporation technologies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LiberoThera Co., Ltd. Comparables
Compare LiberoThera Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abilita Therapeutics | 83% | |
| Confo Therapeutics | 78% | |
| leadXpro AG | 77% |
LiberoThera Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Aug 1, 2024 | ||||
| VC Round | Aug 5, 2021 | ||||
| VC Round | May 14, 2021 |
LiberoThera Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MP Healthcare Venture Management | VC Round |
| Taiho Ventures | VC Round |
| Beyond Next Ventures | VC Round |
| Miyagin Venture Capital | VC Round |
| UTokyo Innovation Platform Co., Ltd. | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 47% MoM.
- Jul 27, 2026
Monthly visitors grew 98% MoM, reaching 1.4K.
LiberoThera Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about LiberoThera Co., Ltd.'s valuation, stock price, and market status.
Is LiberoThera Co., Ltd. a public or private company?
LiberoThera Co., Ltd. is a private company.
What is the current stock price of LiberoThera Co., Ltd.?
LiberoThera Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks LiberoThera Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LiberoThera Co., Ltd. worth (valuation)?
Valuation information for LiberoThera Co., Ltd. is not publicly available.
Can I buy LiberoThera Co., Ltd. stock?
LiberoThera Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LiberoThera Co., Ltd.'s last funding round?
LiberoThera Co., Ltd.'s most recent funding round was VC Round on August 1, 2024.
Who are the main investors in LiberoThera Co., Ltd.?
Key investors in LiberoThera Co., Ltd. include Taiho Ventures, UTokyo Innovation Platform Co., Ltd..
Will LiberoThera Co., Ltd. IPO soon?
No public IPO plans have been announced for LiberoThera Co., Ltd..
How can I track LiberoThera Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in LiberoThera Co., Ltd.'s shares on secondary markets.